Evidence map›Paper›PMID 22824510›Full record

ArticleNeurotoxicology2012

Evaluation of N-butylbenzenesulfonamide (NBBS) neurotoxicity in Sprague-Dawley male rats following 27-day oral exposure.

C V Rider, K S Janardhan, D Rao, J P Morrison, C A McPherson, G J Harry

Abstract read
In one paragraph

Article in Neurotoxicology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Immunotoxicity of N-butylbenzenesulfonamide: impacts on immune function in adult mice and developmentally exposed rats.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. A Review of the Potential of Phytochemicals fromEvidence-based complementary and alternative medicine : eCAM · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

C V RiderToxicology Branch, National Toxicology Program, NIEHS, United States.
K S Janardhanlntegrated Laboratory Systems Inc., RTP, NC, United States.
D Raolntegrated Laboratory Systems Inc., RTP, NC, United States.
J P MorrisonCharles River Pathology Associates, 4025 Stirrup Creek Drive, Suite 150, Durham, NC 27703, United States.
C A McPhersonNTP Laboratory, NIEHS, RTP, NC 27709, United States.
G J HarryNTP Laboratory, NIEHS, RTP, NC 27709, United States. Electronic address: harry@niehs.nih.gov.
National Institute of Environmental Health Sciences · USIntegrated Laboratory Systems, Inc. · USCharles River Associates · US

Funding

Environmentally Induced Alterations In Neuron And Glia Development and AgingZIAES021164 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI HARRY, GAYLIA JEAN · 2009 to 2021
$15.4M
Neuroimmunotoxicology: autoimmunity, inflammation, age, environmental agentsZIAES101623 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI HARRY, GAYLIA JEAN · 2009 to 2012
$1.7M
Intramural NIH HHS ZIA ES021164Intramural NIH HHS ZIA ES101623
6 · The paper itself

Abstract

N-Butylbenzenesulfonamide (NBBS) is widely used as a plasticizer in polyacetals, polyamides, and polycarbonates and has been found in ground water and effluent from wastewater treatment sites. The compound is lipophilic and distributes rapidly to the brain but also clears rapidly and shows little evidence of accumulation. Limited studies in the literature report neurotoxicity of NBBS in rabbits and rats. Adult Sprague-Dawley male rats (Harlan) received corn oil vehicle or NBBS (100, 200, or 400mg/kg/d) via oral gavage (5 ml/kg bwt) daily/5d/week for 27 d. Deaths were observed in the 400mg/kg/d dose group in the first 5d and dosing was decreased to 300 mg/kg/d. No alterations were observed in gait, locomotor activity, and rearing behavior. No histological lesions were observed in the testis, seminal vesicles, coagulating gland, epididymis, and prostate. In the liver, minimal centrilobular hypertrophy was evident in all rats of the high dose group. Contrary to previous reports, there was no evidence of peripheral nerve lesions or gliosis in the hippocampus or cerebellum. mRNA levels for glial fibrillary acidic acid protein, interferon gamma, CXCR-3, intracellular adhesion molecule-1, and CD11b were not altered in the hippocampus while Iba-1 levels were decreased. These data do not support previous reports of neurotoxicity for NBBS within a 4-week exposure regimen; however, neuropathological injury occurring over an extended period of exposure cannot be ruled out and given the potential for human exposure requires further examination.

Indexed as

Toxicity TestsAdministration, OralAnimalsBehavior, AnimalBenzenesulfonamidesBiomarkersDose-Response Relationship, DrugGene Expression RegulationGenitalia, MaleHippocampusLiverMaleMotor ActivityNeurotoxicity SyndromesPlasticizersRatsBenzenesulfonamidesBiomarkersN-butylbenzenesulfonamidePlasticizersRNA, MessengerSulfonamidesWater Pollutants, Chemical

Identifiers

PMID22824510
PMCPMC3491148
OpenAlexW2037379505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.